FindTrial
Sign In

Clinical studies on using BM-MSC to induce transplant immune tolerance in living-related donor kidney transplantation

Clinical studies on using BM-MSC to induce transplant immune tolerance in living-related donor kidney transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008200
Enrollment
Unknown
Registered
2016-03-31
Start date
2009-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney transplantation

Interventions

experimental group:twice MSCs infusion

Sponsors

The second affiliated hospital of Guangzhou medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 20-50 years; pra negative; the amount of HLA mismacth<=2; without any surgical contraindication of kidney transplantation

Exclusion criteria

Exclusion criteria: diabetes mellitus; Mental nerve dysfunction; Coagulation disorders; disease of immune system; hematological system diseases; malignancy

Design outcomes

Primary

MeasureTime frame
rejection rate;graft survival;renal function;—

Secondary

MeasureTime frame
urine volume;—

Countries

China

Contacts

Public ContactPan Guanghui

The second affiliated hospital of Guangzhou medical University

277833665@qq.com+86 13602888877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026